Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Long-Term Disorder of Dialysis”

42 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 42 results

Large-scale testing (Phase 3)Study completedNCT00171080
What this trial is testing

VALID: Study to Compare the Reduction of Predialysis Systolic Blood Pressure With Valsartan Compared to Irbesartan in Patients With Mild to Moderate Hypertension on Long-term Hemodialysis

Who this might be right for
Hypertension
Novartis 86
Testing effectiveness (Phase 2)Ended earlyNCT00372489
What this trial is testing

Extension Study to Evaluate Safety and Tolerability of Peginesatide for Long-Term Treatment of Anemia in Participants With CKD

Who this might be right for
Chronic Renal FailureChronic Kidney DiseaseAnemia
Affymax 81
Not applicableUnknownNCT03820765
What this trial is testing

Cessation of Dialysis Treatment in Reinbek and Geesthacht

Who this might be right for
Complication of Renal DialysisLong-Term Disorder of Dialysis
University of Luebeck 200
Not applicableStudy completedNCT01903213
What this trial is testing

Post-Marketing Surveillance on Long-Term Drug Use of Kiklin (Bixalomer)® Capsules in Patients With Hyperphosphatemia Receiving Peritoneal Dialysis

Who this might be right for
Chronic Renal Failure
Astellas Pharma Inc 123
Large-scale testing (Phase 3)Study completedNCT00317226
What this trial is testing

Long Term Safety Study of (VIT45) Extension Study: Treatment of Anemia in Non-Dialysis Dependent Chronic Kidney Disease

Who this might be right for
Anemia
American Regent, Inc. 145
Testing effectiveness (Phase 2)Study completedNCT01630889
What this trial is testing

Open-Label Extension Study for the Long-Term Efficacy and Safety of Roxadustat in Participants With Dialysis and Non-Dialysis Chronic Kidney Disease

Who this might be right for
Chronic Kidney DiseaseEnd Stage Renal DiseaseAnemia
Kyntra Bio 15
Not applicableStudy completedNCT02687594
What this trial is testing

Non-interventional Study to Investigate the Short and Long Term Real-life Safety, Effectiveness, and Adherence of Velphoro® in Patients With Hyperphosphataemia Undergoing Haemodialysis (HD) or Peritoneal Dialysis (PD)

Who this might be right for
Hyperphosphatemia
Vifor Fresenius Medical Care Renal Pharma 1,400
Testing effectiveness (Phase 2)Ended earlyNCT00453973
What this trial is testing

Extension Study to Evaluate Safety and Tolerability of Peginesatide for Long-Term Treatment of Anemia in Participants With CKD (EU)

Who this might be right for
Chronic Renal FailureChronic Kidney DiseaseAnemia
Affymax 114
Large-scale testing (Phase 3)Study completedNCT01464190
What this trial is testing

Extension Study to Investigate the Long-term Safety, Tolerability and Efficacy of PA21, a Phosphate Binder in Dialysis Patients

Who this might be right for
Chronic Kidney Disease Requiring Chronic Dialysis
Vifor Pharma 659
Large-scale testing (Phase 3)Study completedNCT01554982
What this trial is testing

A Long-Term Safety Extension Trial of Ferric Citrate in Patients With End-Stage Renal Disease (ESRD) on Dialysis

Who this might be right for
End Stage Renal DiseaseKidney FailureRenal Failure+2 more
Keryx Biopharmaceuticals 168
Not applicableStudy completedNCT00944775
What this trial is testing

Exercise and Cardiac Measures in Dialysis Patients

Who this might be right for
Sudden Cardiac Death
Aristotle University Of Thessaloniki 63
Not applicableStudy completedNCT01311999
What this trial is testing

Surveillance and Follow-up for Latent Tuberculosis Infection and Risk of Developing Active Tuberculosis in Patients Receiving Long-term Dialysis

Who this might be right for
To Predict the Potential of Development of Active Tuberculosis in Those Receiving Long-term Dialysis by Using Interferon-gamma Release Assy
National Taiwan University Hospital 234
Not applicableStudy completedNCT01872429
What this trial is testing

Short- and Long-Term Impact of Subtotal Parathyroidectomy on the Achievement of Bone and Mineral Parameters Recommended by Clinical Practice Guidelines in Dialysis Patients

Who this might be right for
Hyperparathyroidism
Far Eastern Memorial Hospital 401
Not applicableNot Yet RecruitingNCT07156123
What this trial is testing

PD Catheter Data Collection

Who this might be right for
Renal Insufficiency / Therapy
Fresenius Medical Care Deutschland GmbH 300
Post-approval studies (Phase 4)Study completedNCT03256838
What this trial is testing

Assess the Safety and Efficacy of Nephoxil® in Subjects With End Stage Renal Disease (ESRD) on Dialysis

Who this might be right for
Kidney Failure, ChronicEnd-stage Renal DiseasePhosphorus Metabolism Disorders+1 more
Panion & BF Biotech Inc. 202
Testing effectiveness (Phase 2)Ended earlyNCT01576146
What this trial is testing

Open-label Study to Assess the Long-term Safety and Efficacy of Etelcalcetide (Also Known as AMG 416 or KAI-4169) in Patients With Secondary Hyperparathyroidism

Who this might be right for
Secondary Hyperparathyroidism
KAI Pharmaceuticals 30
Post-approval studies (Phase 4)Study completedNCT03988920
What this trial is testing

A Long-Term Study of Tenapanor Alone or in Combination With Sevelamer in Patients With CKD on Dialysis and HP

Who this might be right for
HyperphosphatemiaEnd Stage Renal Disease
Ardelyx 172
Large-scale testing (Phase 3)Study completedNCT00772382
What this trial is testing

Study of MCI-196 in Chronic Kidney Disease Stage V Subjects on Dialysis With Hyperphosphatemia

Who this might be right for
Chronic Kidney DiseaseDialysisHyperphosphatemia
Tanabe Pharma Corporation 116
Large-scale testing (Phase 3)Ended earlyNCT01814917
What this trial is testing

Long-term Extension Study of MCI-196

Who this might be right for
Chronic Kidney DiseaseDialysisHyperphosphatemia+1 more
Tanabe Pharma Corporation 6
Large-scale testing (Phase 3)Study completedNCT00542815
What this trial is testing

MCI-196 in Chronic Kidney Disease Stage V Subjects on Dialysis With Hyperphosphatemia

Who this might be right for
Chronic Kidney DiseaseDialysisHyperphosphatemia
Tanabe Pharma Corporation 632
Load More Results